miR-137 suppresses cell growth and extracellular matrixdegradation through regulating ADAMTS-5 in chondrocytes

Area of Science:

• Biochemistry
• Molecular Biology
• Rheumatology

Background:

• Osteoarthritis (OA) is a prevalent degenerative joint disease.
• MicroRNAs (miRNAs) are implicated in various diseases, including OA.
• The specific role and mechanism of miR-137 in OA pathogenesis are largely unknown.

Purpose of the Study:

• To investigate the involvement and mechanism of miR-137 in the development of osteoarthritis.
• To determine if miR-137 targets ADAMTS-5 and affects its expression.
• To elucidate the effect of miR-137 on chondrocyte function and OA progression.

Main Methods:

• Assessing miR-137 expression in chondrocytes and OA patient tissues.
• Utilizing dual-luciferase reporter assays to identify miR-137 targets.
• Overexpressing miR-137 in chondrocytes to evaluate its functional impact.
• Measuring cell growth, extracellular matrix degradation, and inflammation markers.

Main Results:

• Interleukin-1 beta (IL-1β) reduced miR-137 expression in chondrocytes.
• miR-137 expression was significantly lower in OA patients compared to controls.
• ADAMTS-5 was identified as a direct target of miR-137.
• Elevated miR-137 expression decreased ADAMTS-5 protein levels and suppressed OA-related cellular processes.
• ADAMTS-5 expression was higher in OA tissues and negatively correlated with miR-137 levels.

Conclusions:

• miR-137 acts as a suppressor of osteoarthritis progression.
• The mechanism involves inhibiting chondrocyte proliferation, extracellular matrix degradation, and inflammation.
• miR-137 targets ADAMTS-5, a key enzyme in matrix degradation.
• These findings highlight miR-137 as a potential therapeutic target for OA.